COMP <GO>
AMAT vs ORCL // RSI-14 & 200D SMA MOMENTUM
Applied Materials Inc. (NASDAQ) VS. Oracle Corporation (NYSE) • 15-METRIC TALLY: AMAT 5
— ORCL 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: AMAT
LAST: $421.66 (+1.36%) • MKT CAP: $334.63B
rsi-technicals
46.1
LAST: $139.56 (-3.44%) • MKT CAP: $421.99B
rsi-technicals
45.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMAT VS. ORCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMAT | ORCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.50% | 11.39% | +13.11 | AMAT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.7x | 17.5x | +15.16 | ORCL | /valuation <GO> |
| Free Cash Flow Yield | 1.70% | -7.27% | +8.97 | AMAT | /fcf-yield <GO> |
| Operating Margin | 29.20% | 32.12% | -2.92 | ORCL | /operating-margins <GO> |
| Net Profit Margin | 24.70% | 26.36% | -1.66 | ORCL | /net-margins <GO> |
| Revenue Growth (YoY) | 4.40% | 21.62% | -17.22 | ORCL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.41% | 1.53% | -1.12 | ORCL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.63 | 1.52 | +15.11 | AMAT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | AMAT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 11.57% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 46.1 | 45.5 | +0.60 | AMAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.29 | 1.37 | -0.08 | ORCL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 44.5x | 16.5x | +27.96 | ORCL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $334.63B | $421.99B | -$87.36B | ORCL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMAT REV | ORCL REV | AMAT GROSS % | ORCL GROSS % | AMAT FCF | ORCL FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $67.36B | — | — | — | -$23.69B |
| FY 2025 | $28.37B | $57.40B | 48.7% | — | $5.70B | -$394.0M |
| FY 2024 | $27.18B | $52.96B | 47.5% | — | $7.49B | $11.81B |
| FY 2023 | $26.52B | $49.95B | — | — | $7.51B | $8.47B |
| FY 2022 | — | $42.44B | — | — | — | $5.03B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMAT // BETA 1.29
ORCL // BETA 1.37